Summary
Managing and treating mitral valve disease have both changed radically over the past few years and now include transcatheter as well as surgical approaches. What does the future hold for mitral valve repair and replacement? During the most recent STS Annual Meeting, Vinod Thourani, MD, asked that question of Steven F. Bolling, MD, Gorav Ailawadi, MD, and Wilson Y. Szeto, MD. They also discussed new tools and technologies, making sure that cardiothoracic surgeons are involved on the care team, and training with transcatheter techniques.
Vinod Thourani, MD
Piedmont Heart Institute
Atlanta, GA
Steven F. Bolling, MD
University of Michigan
Ann Arbor
Gorav Ailawadi, MD
University of Virginia
Charlottesville
Wilson Y. Szeto, MD
University of Pennsylvania
Philadelphia